Saniona AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

05.01.22	Saniona to participate in multiple upcoming virtual investor conferences (GlobeNewswire)
28.12.21	Saniona Initiates Phase 2b Clinical Trial of Tesomet for Prader-Willi Syndrome (GlobeNewswire)
02.12.21	Saniona Chairman J. Donald deBethizy and CEO Rami Levin, as well as additional members of the board and management, purchase Saniona shares in the open market (GlobeNewswire)
25.11.21	Saniona AB’s Nomination Committee for the Annual General Meeting 2022 (GlobeNewswire)
18.11.21	Saniona publishes its interim report for the third quarter of 2021 (GlobeNewswire)
17.11.21	Saniona Initiates Phase 2b Clinical Trial of Tesomet for Hypothalamic Obesity (GlobeNewswire)
18.10.21	Saniona completes submission of manufacturing data for Tesomet capsules to U.S. FDA (GlobeNewswire)
06.10.21	Saniona to participate in multiple upcoming virtual investor conferences (GlobeNewswire)
16.09.21	Saniona appoints Robert Hoffman to Board of Directors as Chair of the Audit Committee (GlobeNewswire)
16.09.21	Bulletin from the Saniona AB extraordinary shareholders’ meeting on September 16, 2021 (GlobeNewswire)
15.09.21	Saniona appoints Wendy Dwyer as Chief Business Officer (GlobeNewswire)
26.08.21	Saniona publishes its interim report for the second quarter of 2021 (GlobeNewswire)
20.08.21	Notice of Saniona AB extraordinary shareholders’ meeting to elect new member of the board of directors (GlobeNewswire)
26.07.21	Saniona Receives U.S. FDA Orphan Drug Designation for Tesomet in Hypothalamic Obesity (GlobeNewswire)
14.07.21	Saniona secures SEK 87 million ($10 million) non-dilutive term loan (GlobeNewswire)
30.06.21	Saniona Initiates Phase 1 Clinical Trial of SAN711 (GlobeNewswire)
29.06.21	Bulletin from the Saniona AB extraordinary shareholders’ meeting on June 29, 2021 (GlobeNewswire)
25.06.21	Saniona provides update on ongoing review of tesofensine in Mexico (GlobeNewswire)
08.06.21	Saniona to Present Preclinical Data on SAN711 at the 7th Congress of the European Academy of Neurology (GlobeNewswire)
26.05.21	Notice of Saniona AB extraordinary shareholders’ meeting (GlobeNewswire)
26.05.21	Bulletin from the Saniona AB annual shareholders’ meeting on May 26, 2021, and information regarding planned extraordinary shareholders’ meeting (GlobeNewswire)
26.05.21	Saniona publishes its interim report for the first quarter of 2021 (GlobeNewswire)
20.05.21	Saniona Hosts Research and Development (R&D) Day on Proprietary Ion Channel Drug Discovery Engine and Pipeline Programs (GlobeNewswire)
12.05.21	Saniona to Host Research and Development (R&D) Day on Leveraging Ion Channel Targeting Expertise for Rare Diseases (GlobeNewswire)
10.05.21	Saniona Launches New Video Series to Highlight the Impact of Prader-Willi Syndrome and Hypothalamic Obesity on Patients and Caregivers (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.00	2.85 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.64	2.27 %	K V
Geberit	524.60	1.55 %	K V
Alcon	77.00	1.45 %	K V
UBS Group	28.36	0.78 %	K V
Lonza Grp	524.80	0.61 %	K V
Kuehne+Nagel Int	208.70	0.34 %	K V
Nestle	76.20	0.32 %	K V
Swisscom	505.50	0.00 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Saniona AB

Aktien Top/Flop

Meistgelesene Nachrichten